Carlos E Muskus (Carlos Muskus)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

Nature communications

Pathogens (Basel, Switzerland)

Scientific reports

Journal of computer-aided molecular design

Universidad de Antioquia

Universidad de Antioquia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad de Antioquia Feb 05 1998

Colombia

Profesor Titular :: Instituto de Investigaciones Medicas

Education History

Universidad de Antioquia Jun 05 2003

Colombia

PHD :: Facultad de Medicina

Publications

Sneider A Gutierrez Guarnizo, Elena B Tikhonova, Andrey L Karamyshev, Carlos E Muskus, Zemfira N Karamysheva
Translational reprogramming as a driver of antimony-drug resistance in Leishmania. Nature communications 14 (1) (2023)
Sneider A Gutierrez Guarnizo, Elena B Tikhonova, Andrey L Karamyshev, Carlos E Muskus, Zemfira N Karamysheva
Translational reprogramming as a driver of antimony-drug resistance in Leishmania. Nature communications 14 (1) (2023)
Sneider A Gutierrez Guarnizo, Elena B Tikhonova, Andrey L Karamyshev, Carlos E Muskus, Zemfira N Karamysheva
Translational reprogramming as a driver of antimony-drug resistance in Leishmania. Nature communications 14 (1) (2023)
Sneider A Gutierrez Guarnizo, Elena B Tikhonova, Andrey L Karamyshev, Carlos E Muskus, Zemfira N Karamysheva
Translational reprogramming as a driver of antimony-drug resistance in Leishmania. Nature communications 14 (1) (2023)
Sneider A Gutierrez Guarnizo, Elena B Tikhonova, Andrey L Karamyshev, Carlos E Muskus, Zemfira N Karamysheva
Translational reprogramming as a driver of antimony-drug resistance in Leishmania. Nature communications 14 (1) (2023)
Santiago Rendon-Marin, Carolina Quintero-Gil, Diego Guerra, Carlos E Muskus, Julián Ruíz-Sáenz
Retraction: Rendon-Marin et al. Canine Morbillivirus from Colombian Lineage Exhibits In Silico and In Vitro Potential to Infect Human Cells. Pathogens 2021, 10 , 1199. Pathogens (Basel, Switzerland) 11 (11) (2022)
Sneider A Gutierrez Guarnizo, Zemfira N Karamysheva, Elkin Galeano, Carlos E Muskus
Metabolite Biomarkers of Leishmania Antimony Resistance. Cells 10 (5) (2021)
Santiago Rendon-Marin, Carolina Quintero-Gil, Diego Guerra, Carlos E Muskus, Julián Ruíz-Sáenz
Canine Morbillivirus from Colombian Lineage Exhibits In Silico and In Vitro Potential to Infect Human Cells. Pathogens (Basel, Switzerland) 10 (9) (2021)
Rodrigo Ochoa, Amaya Ortega-Pajares, Florencia A Castello, Federico Serral, Dario Fernández Do Porto, Janny A Villa-Pulgarin, Rubén E Varela-M, Carlos E Muskus
Identification of Potential Kinase Inhibitors within the PI3K/AKT Pathway of Leishmania Species. Biomolecules 11 (7) (2021)
Yeneiris Villero-Wolf, Salim Mattar, Andrés Puerta-González, German Arrieta, Carlos E Muskus, Richard Hoyos-López, Hernando Pinzon, Dioselina Peláez-Carvajal
Genomic epidemiology of Chikungunya virus in Colombia reveals genetic variability of strains and multiple geographic introductions in outbreak, 2014. Scientific reports 9 (1) (2019)
Christian Bustamante, Rodrigo Ochoa, Claudia Asela, Carlos E Muskus
Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations. Journal of computer-aided molecular design 33 (9) (2019)

Carlos E Muskus.css-eqlu8i{font-size:small;padding-left:4px;} (Carlos Muskus)

Publication Activity (10 Years)

Top Topics

Top Venues

Carlos E Muskus (Carlos Muskus)